athenade, Author at Alphina Therapeutics - Page 2 of 2

Home
Team
Careers
Contact
News

Select Page

Alphina Therapeutics nabs crack leaders hip team amid $45MM Series A financing

by athenade | Jun 18, 2021 | Uncategorized

Next Entries »

Search

Recent Posts

Founder Dr. Ranjit Bindra named Power 25: Healthcare 2021 by New Haven Biz
Pre-seed round announcement with Connecticut Innovations and HighCape Capital
Blavatnik award announcement
CSO announcement
SAB members announcement

Alphina is developing a best-in-class small molecule NAMPT inhibitor to meaningfully improve the lives of patients across a wide range of solid tumor indications.

Home
Team
Careers
Contact
News

© 2025 Alphina Therapeutics All Rights Reserved.